Detalhe da pesquisa
1.
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
Am J Hematol
; 97(3): 267-273, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978743
2.
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.
Br J Haematol
; 193(2): 380-385, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216966
3.
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma.
Am J Hematol
; 96(3): 330-337, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326116
4.
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
Br J Haematol
; 188(3): 394-403, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468508
5.
Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial.
Eur J Haematol
; 104(5): 443-458, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880006
6.
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Am J Hematol
; 94(7): 751-756, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945330
7.
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
Am J Hematol
; 93(10): 1207-1210, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016549
8.
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
Am J Hematol
; 96(1): E35-E38, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33068019
9.
Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
Am J Hematol
; 91(11): 1123-1128, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27501122
10.
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 21(12): 2039-2051, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26428082
11.
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity.
Am J Hematol
; 95(3): E60-E62, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840857
12.
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.
Lancet Oncol
; 15(13): 1503-1512, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25456369
13.
Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
Br J Haematol
; 167(4): 500-5, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25113422
14.
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
Am J Hematol
; 94(5): E141-E143, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773682
15.
Authors' Reply.
J Am Soc Nephrol
; 29(12): 2902, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389728
16.
Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective.
Mayo Clin Proc
; 99(1): 15-21, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108685
17.
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Am J Hematol
; 88(5): 375-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23508840
18.
Natural history of amyloidosis isolated to fat and bone marrow aspirate.
Br J Haematol
; 179(1): 170-172, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27328653
19.
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
Blood Cancer J
; 12(4): 67, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440099
20.
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma.
Blood Adv
; 6(11): 3268-3279, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175355